Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AMD device developer NeoVista achieves $41mm via third round

Executive Summary

NeoVista (eye devices) has raised $41mm through its Series C financing. The oversubscribed round was led by new investor Essex Woodlands Health Ventures, which was joined by fellow new backer MPM Capital and returning shareholders Versant Ventures, SV Life Sciences, Carlyle Group, and Accuitive Medical Ventures.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies